DILIC
UTHR icon

Dai-ichi Life Insurance Company’s United Therapeutics UTHR Stock Holding History

Dai-ichi Life Insurance Company’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.48M Buy
8,277
+1,660
+25% +$935K 0.1% 182
2026
Q1 		$3.92M Sell
6,617
-769
-10% -$383K 0.11% 172
2025
Q4 		$3.6M Sell
7,386
-510
-6% -$238K 0.09% 193
2025
Q3 		$3.31M Buy
7,896
+1,244
+19% +$418K 0.08% 206
2025
Q2 		$1.91M Sell
6,652
-888
-12% -$265K 0.05% 267
2025
Q1 		$2.32M Sell
7,540
-197
-3% -$67.5K 0.07% 239
2024
Q4 		$2.73M Sell
7,737
-53
-0.7% -$19.5K 0.08% 227
2024
Q3 		$2.79M Sell
7,790
-1,412
-15% -$477K 0.07% 235
2024
Q2 		$2.93M Buy
9,202
+873
+10% +$231K 0.07% 230
2024
Q1 		$1.91M Sell
8,329
-2,561
-24% -$578K 0.04% 306
2023
Q4 		$2.4M Sell
10,890
-660
-6% -$152K 0.05% 274
2023
Q3 		$2.61M Hold
11,550
– – 0.06% 255
2023
Q2 		$2.55M Hold
11,550
– – 0.05% 263
2023
Q1 		$2.59M Buy
+11,550
New +$2.85M 0.06% 261
2019
Q2 		– Sell
-3,000
Closed -$352K – 548
2019
Q1 		$352K Buy
+3,000
New +$350K 0.01% 472

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Dai-ichi Life Insurance Company's UTHR Position: Q2 2026 in Review

Dai-ichi Life Insurance Company increased its United Therapeutics (UTHR) stake by 25% in Q2 2026, buying an estimated $935K and bringing the position to 8,277 shares worth $4.48M. The position accounts for 0.1% of the portfolio, ranked #182.

Dai-ichi Life Insurance Company first reported a position in UTHR in Q1 2019 and has held it in 15 quarters since. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Dai-ichi Life Insurance Company held 8,277 shares of United Therapeutics worth $4.48M as of Q2 2026.
  • Dai-ichi Life Insurance Company bought 1,660 United Therapeutics shares in Q2 2026, an estimated $935K.
  • United Therapeutics made up 0.1% of Dai-ichi Life Insurance Company's portfolio in Q2 2026, its #182 holding.
  • Dai-ichi Life Insurance Company first reported a position in United Therapeutics in Q1 2019 and has held it in 15 quarters since.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Dai-ichi Life Insurance Company's 13F filing for Q2 2026, filed 12 Aug 2026.